Wu Kaimin was worried her dissertation proposal might not be approved. Now, her research could fundamentally alter how ...

When we think about Parkinson’s disease, most of us picture trembling hands or a shuffling walk. But what if your nose could ...

Glyoxalase Domain-containing Protein 4 (GLOD4), the First Identified in a New Class of Enzymes Called Nitrases, Generates Nitrated ...

Researchers have discovered a new biomarker for Parkinson’s that could ... did not have misfolded alpha-synuclein, suggesting a different biological basis for their disease.

A fluorescent micrograph of a section of brain affected by Parkinson's disease. Neuron nuclei are blue, while the protein ...

Parkinson's disease (PD), the second most common neurodegenerative ... lipid peroxidation and prevent the accumulation of alpha-synuclein. The accumulation of this protein is a key feature of ...

Previous research led by Sette and Lindestam Arlehamn showed that many Parkinson's disease patients have T cells that target a protein called alpha-synuclein. This T cell response was linked to ...

Previous research led by Sette and Lindestam Arlehamn showed that many Parkinson's disease patients have T cells that target a protein called alpha-synuclein. This T cell response was linked to ...

An experimental therapy for Parkinson's disease being developed by ... and also after another alpha-synuclein drug tested in the disease – Biogen's cinpanemab – was abandoned in 2021 after ...

As a leading neurodegenerative disorder, Parkinson's disease is characterized by ... Central to this degeneration is the accumulation of alpha-synuclein, a protein that forms toxic aggregates ...